Company: PHAT
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001193125-25-137094
Chunk: 2

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01. Financial Statements and Exhibits.

  (d)      Exhibits  

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      FDA Letter, dated June 6, 2025                                               
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                          PHATHOM PHARMACEUTICALS, INC.                                           
  Date: June 6, 2025      By:                                /s/ Steven Basta                     
                                                             Steven Basta                         
                                                             President & Chief Executive Officer